Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.

MLA

Michihata, Nobuaki, et al. “Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.” Clinical Pediatrics, vol. 54, no. 11, Oct. 2015, pp. 1076–80. EBSCOhost, https://doi.org/10.1177/0009922814566932.

APA

Michihata, N., Matsui, H., Fushimi, K., & Yasunaga, H. (2015). Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm. Clinical Pediatrics, 54(11), 1076–1080. https://doi.org/10.1177/0009922814566932

Chicago

Michihata, Nobuaki, Hiroki Matsui, Kiyohide Fushimi, and Hideo Yasunaga. 2015. “Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.” Clinical Pediatrics 54 (11): 1076–80. doi:10.1177/0009922814566932.